| Jurenka B 1 ., Biebl O.2 , Kubricht V.1 , Stern M.1 , Šoupal J.2: Ultrafast Short-acting Beta Blocker Esmolol (Brevibloc (R)  ) for Perioperative Myocardial Protection
 | 100 | 
  
    | Rupeht J.1 , Bouvy-Berends E. C. M.2: Office-based Anaesthesia for Dentistry in the Disabled: Rotterdam Approach*
 | 103 | 
  
    | Polívková J., Závada J., Popelíková H., Ehler Z.: Patient with Haematologic Malignity and Sepsis with Multiorgan Failure
 | 106 | 
  
    | Mixa V.1 , Cvachovec K.1 , Sumerauer D.2 , Mališ J.2 , Hurychová I.3 , Vyhnánek M.4 , Hríbal Z.5: Severe Complication of Inserting Central Venous Dialysis Catheter in Patient with Haematologic Malignity
 | 111 | 
  
    | Kolár M.1 , Balík M.1 , Marková M.2 , Zikešová E.3: Prognostic Value of Some Characteristic Sings in Patients with Haematologic Malignity in Intensive Care
 | 115 | 
  
    | Marková M., Cetkovský P.: The Complications of Allogenic Haematopoietic Cells Transplantation which Requited Intensive Care
 | 119 | 
  
    | Kolár M.1 , Balík M.1 , Marková M.2 , Zikešová E.3: Intensive Care in Bone Marrow Transplanted Patients
 | 121 | 
  
    | Rušavý Z., Suchá R., Langhamerová E., Šrámek V., Lacigová S., Tešínský P.: Influence of All-in-one System on Biological Insulin Availability
 | 124 | 
  
    | Refka M., Janíková M., Tonkovicová M., Machová J.: Bronchoalveolar Lavage as a Therapeutic Way for Alveolar Proteinosis
 | 127 | 
  
    | Kos Z.1 , Janda R.1 , Polonyová E.2: Patient with ARDS and Haematologic Malignity – a Case Report
 | 130 | 
  
    | Stibor B., Mannová J., Gál R., Zimová I., Cundrle I.: TUR Syndrome – Case Reports
 | 133 | 
  
    | Sovová E.1 , Klementa B.2 , Kociánová E.1 , Marek O.2 , Lukl J.1: Public Medial Action as Possibility for Teaching Basic Life Support
 | 136 |